41st Annual Report of HCP Plastene Bulkpack Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HCP Plastene Bulkpack reported a strong turnaround in FY25. Standalone revenue from operations jumped to Rs. 11,808.53 lakh from Rs. 4,554.91 lakh (up ~159%), while consolidated revenue rose to Rs. 46,343.54 lakh from Rs. 29,455.55 lakh (up ~57%). The company swung from a standalone loss of Rs. 276.38 lakh to a profit of Rs. 574.37 lakh, and consolidated PAT surged to Rs. 1,341.96 lakh from Rs. 30.81 lakh. Standalone EBDITA improved sharply to Rs. 1,503.2 lakh from Rs. 254.02 lakh, with margins expanding to about 12.7% from 5.6%. No dividend was declared. The company achieved minimum public shareholding via an Offer for Sale, reducing promoter holding to 75%, and signed an MOU with Saudi Arabia's Saeed Ghodran Group to set up a JV for BOPP/jumbo woven bag manufacturing.
This is a positive turnaround story for shareholders, with strong revenue growth, margin expansion, and a return to profitability at both standalone and consolidated levels. The international JV signals future growth potential, but the absence of a dividend and some past compliance delays (RPT disclosures, board meeting outcome submissions) noted by the secretarial auditor are minor negatives to watch.